Bracco Gets Second Chance in Jubilant Case Over Imaging Agent

The U.S. International Trade Commission said it will review a judge’s findings that deemed invalid three Bracco patents for a radioisotope infusion system used in heart-imaging procedures, the agency said in a notice posted on its website.

• Bracco claims Jubilant Life Sciences’s Ruby imaging agent infringes three patents for strontium-rubidium radioisotope infusion systems.
• Bracco is seeking an order to block imports of Jubilant DraxImage systems made in Canada.
• Patents cover a computer-controlled medical device, plus the method of making it and ways to use it to infuse a patient with radioisotope rubidium-82 during an imaging process.
• Several nuclear medicine technologists ...